Accurate Planning and Guidance of Bronchoscopy for Lung Cancer Management
The main objective of this project is to demonstrate the potential of three new technical innovations for improving state-of-the-art bronchoscopy guidance systems.
Through this study, we plan to generate preliminary data that demonstrates the potential of three new innovations for enhancing existing bronchoscopy systems in the live clinical setting.
The goal is to demonstrate the potential of the new innovations: 1. to demonstrate the potential of a new methodology to reduce errors from CT-to-body divergence in the live clinical setting, 2. to demonstrate the potential of the new methodologies to enable live rerouting of a guided bronchoscopy, and 3. to perform automatic real-time mucosal lesion detection during a standard airway examination.
These innovations could potentially improve current image-guided bronchoscopy systems and be used for future robotic bronchoscopy.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: William E Higgins, PhD
- Telefonnummer: 814-865-0186
- E-Mail: weh2@psu.edu
Studieren Sie die Kontaktsicherung
- Name: Rebecca Bascom, MD, MPH
- Telefonnummer: 717-531-2925
- E-Mail: rbascom@pennstatehealth.psu.edu
Studienorte
-
-
Pennsylvania
-
Hershey, Pennsylvania, Vereinigte Staaten, 17033
- Penn State Milton S. Hershey Medical Center
-
Kontakt:
- Timothy P Sheehan, MS
- Telefonnummer: 284024 717-531-0003
- E-Mail: tsheehan@pennstatehealth.psu.edu
-
Unterermittler:
- Rebecca Bascom, MD, MPH
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- a planned clinical bronchoscopy to evaluate abnormal lung parenchyma and/or central chest lymph nodes;
Radiology images, previously obtained for clinical purposes, that meet technical specifications and are available on our team's Radiology research server or can be uploaded from the Hershey Medical Center clinical image storage system.
- a clinical CT scan performed at Hershey Medical Center, AND
- Either one of two additional clinically available scans:
- CT/PET study OR
- a clinical CT scan that includes inspiratory and expiratory images
- Must be able to read, write, and speak English.
Exclusion Criteria:
- Special classes of subjects that will be excluded are pregnant women because clinical CT scans and CT/PET studies are avoided because of the potential for radiation injury to the fetus.
- Mentally incompetent subjects will be excluded. They will be identified as such because their treating clinician will have deemed them unable to provide consent for their clinical procedure. The clinical record will indicate whether the patient is providing consent or a surrogate decision-maker has been needed. Patients with a surrogate decision-maker will be excluded.
- We will exclude prisoners and institutionalized individuals because their autonomy is compromised by their status, and the study provides no direct benefit from which they would be excluded. Individuals who become prisoners or are institutionalized after giving consent but before their diagnostic procedure would also be excluded. Their clinical record will identify if they are in custody.
- Children are not part of this project because they do not get lung cancer. Therefore, we do not provide processes for meeting requirements for parental permission and child assent.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Anzahl der Gruppen / Kohorten
Kohorten und Interventionen
Gruppe / KohorteGruppe / Kohorte |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Consented Clinical Bronchoscopy Cohort
Lung cancer patients, scheduled for bronchoscopy, who are consented for bronchoscopy by the Virtual Navigator.
|
The Virtual Navigator guidance computer is interfaced to the bronchoscopy hardware to tap off the live bronchoscopy video feed.
The standard OR medical team (technicians, clinical fellows, et al.) is on hand, and standard clinical facilities (e.g., fluoroscopy, CT/PET image viewer) are available.
Our technical team is also present to record all procedural video and computer display information.
It also operates the guidance computer during the guided procedure and offers any assistance in case of unanticipated issues.
The participant's clinical bronchoscopy will be recorded by the radiology imaging management system.
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Functionality of CTBD Compensation
Zeitfenster: 15 minutes
|
Establish the functionality of the CTBD compensation methodology during a live guided bronchoscopy to a preselected ROI.
|
15 minutes
|
|
Procedure time of CTBD Compensation
Zeitfenster: 15 minutes
|
Total live procedure time taken to complete bronchoscope navigation to the ROI.
|
15 minutes
|
|
Functionality of Rerouting Methodology
Zeitfenster: 15 minutes
|
Functionality of the rerouting methodology during a live guided bronchoscopy to a preselected ROI for the situation that an airway branch along the preplanned airway route to the ROI is unnavigable.
|
15 minutes
|
|
Procedure time of Rerouting Methodology
Zeitfenster: 15 minutes
|
Total live procedure time taken to complete bronchoscope navigation to the ROI, including rerouting.
|
15 minutes
|
|
Functionality of Rerouting to a new ROI
Zeitfenster: 15 minutes
|
Functionality of the rerouting methodology during a live guided bronchoscopy to a preselected ROI for the situation where the system is rerouted to a new ROI during navigation.
|
15 minutes
|
|
Procedure time of Rerouting Methodology to a new ROI
Zeitfenster: 15 minutes
|
Total live procedure time taken to complete bronchoscope navigation to a preselected ROI, including rerouting to a new ROI during navigation.
|
15 minutes
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Hauptermittler: William E Higgins, PhD, Penn State University
- Studienleiter: Rebecca Bascom, MD, MPH, Milton S. Hershey Medical Center
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- 28052
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .